Baxter Obtains U.S. FDA Emergency Use Authorization for Oxiris Blood Purification Filter for COVID-19 Treatment
Baxter International Inc. (BAX)
Last baxter international inc. earnings: 4/30 07:15 am
Check Earnings Report
US:NYSE Investor Relations:
investor.baxter.com
Company Research
Source: Business Wire
Only filter set available in the U.S. to reduce pro-inflammatory cytokine levels in the blood, including use in continuous renal replacement therapy (CRRT), for confirmed COVID-19 cases admitted to the ICU with confirmed or imminent respiratory failure who require blood purificationSupport from U.S. Food and Drug Administration (FDA) enabled accelerated authorization processValidated for use with Baxter’s leading blood purification systems, PrisMax and PrismaflexSupplements Baxter’s efforts to increase supply of acute dialysis products that are in high demand DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received emergency use authorization (EUA) from the U.S. FDA for the company’s Oxiris filter set to treat patients who have confirmed COVID-19 and have been admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure in need of blood purification therapy to reduce pro-inflammatory
Show less
Read more
Impact Snapshot
Event Time:
BAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAX alerts
High impacting Baxter International Inc. news events
Weekly update
A roundup of the hottest topics
BAX
News
- Baxter International Inc. (NYSE: BAX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Baxter Appoints Jeffrey A. Craig to Its BoardBusiness Wire
- Blood Pressure Cuffs Market Analysis Report 2024 [Yahoo! Finance]Yahoo! Finance
- 50 stocks to invest during the bull steepening – Part 2 [Seeking Alpha]Seeking Alpha
- Meningococcal VaccinesGlobal Strategic Business Report to 2030 Featuring Baxter International, Bio-Med, GlaxoSmithKline, Pfizer, Sanofi, and Serum Institute of India Among Others [Yahoo! Finance]Yahoo! Finance
BAX
Earnings
- 8/6/24 - Beat
BAX
Sec Filings
- 9/13/24 - Form 144
- 9/11/24 - Form 4
- 9/11/24 - Form 3
- BAX's page on the SEC website